FOX vs TGTX · P/E 13, $24.49B cap vs P/E 18, rev $240.3M
Fox Corp Class B (FOX) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
FOX does not have a complete income-statement cache yet.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the FOX and TGTX stock pages for the full models.
Not investment advice.